Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... focused on the development of therapeutic and prophylactic vaccines based on proprietary recombinant strains of the bacterium Listeria monocytogenes, announced completion of its Series A-1 ... these two important diseases are appropriate for the initial application of the Listeria technology, and we plan to leverage this versatile platform for many other applications. ...
2009 NOV 23 ... technologies to transform the $100 billion biologics marketplace, which is comprised of recombinant proteins, monoclonal antibodies, and vaccines. In particular, Alnylam is ... RNAi therapeutics company, is providing an update on its RNAi pipeline, platform, and technology at its R&D Day being held in New York today. Alnylam scientists and management will be ...
2009 NOV 23 ... - Saturday, November 7, 2009 and Sunday, November 8, 2009 About DX-88 for HAE DX-88, a recombinant, small protein, was discovered utilizing Dyax's proprietary phage display technology ...
2009 NOV 28 ... and the $1.2 million non-cash expense in 2009 associated with in-licensing related to recombinant human alpha fetoprotein. The decrease in the nine-month expense comparison was due to ... requirements. It is also an important demonstration of LFB's commitment to GTC's technology and products," stated Geoffrey F. Cox, Ph.D., GTC's Chairman and Chief Executive ...
2009 NOV 23 ... "Rhizosecretion is an attractive technology for the production of recombinant proteins from transgenic plants. However, to date, yields of plant-derived recombinant ...
2009 NOV 24 ... These affinity tags are frequently used by bioengineers and biochemists to produce recombinant enzymes, peptides, hormones and antibodies. Successful coupling of ligands to Pluronic ... ligands to demonstrate heavy metal ion binding and re-use is reported. Central to this technology are the easy to manufacture membranes and a biocompatible Pluronic ™ surfactant ...
2009 NOV 24 ... revealed an intimate association of CLU with SPAM1. Both plasma and recombinant CLU had a dose-related effect on transfer efficiency: high concentrations reduced and ... conditions for membrane-free GPI-linked protein transfer in vitro and could lead to technology for improving fertility or treating sperm pathology by the addition of relevant ...
2009 NOV 23 ... xenovorans that encodes a novel cupin protein (Bxe_A2876) of unknown function. Recombinant Bxe_A2876, as isolated from Escherichia coli cell extract, was a homotetramer in ... For additional information, contact B. Nidetzky, Graz University Technology, Institute Biotechnology & Biochemistry Engineering, Petersgasse 12-1, A-8010 Graz, ...
2009 NOV 23 ... and colleagues published their study in the Journal of Immunotherapy (Affitoxin-A Novel Recombinant, HER2-specific, Anticancer Agent for Targeted Therapy of HER2-positive Tumors. Journal ... oxidation, or reduction steps (luring its purification. Using surface plasmon resonance technology and competitive binding assays, we have shown that Affitoxin binds specifically to HER2 ...
2009 NOV 17 ... protective immune responses in animals. We demonstrate here for the first time that the recombinant form of Spy0416 is capable of IL-8 degradation in vitro in a concentration-and ... of neutrophils to an infection site." "By applying the ANTIGENome technology and using human serum antibodies, we identified Spy0416, annotated as ScpC, as a ...
2009 NOV 16 ... presentation on the recent approval of a follow-on version of Pfizer's Genotropin (recombinant human growth hormone), and the beginning of the end of an era where biopharmaceuticals ... even after expiration of their patent protection at GTCbio's Antibody Partnering & Technology Summit on October 29-30, 2009 in San Francisco, CA. Yakatan's session will ...
2009 NOV 16 ... appearance of a new class of drugs which for simplicity can be referred to as the recombinant protein. Growth in this class has been driven by advances in biotechnology and ... important trend - the use and growing reliance of drug developers on specialty device technology CSOs and CMOs. Greystone Associates examines the current landscape and ...
2009 NOV 24 ... in a hand-over-hand walk, with the two heads advancing alternately.""Recombinant kinesin constructs with short stalks have been found to ''limp'', i.e., exhibit ... contact information for the Biophysical Journal is: Cell Press, 600 Technology Square, 5TH Floor, Cambridge, MA 02139, USA.Keywords: City:Stanford, ...
2009 NOV 23 ... for injection) in the U.S. The Cubist product pipeline includes ecallantide, a recombinant human protein in Phase 2 clinical trials - CONSERV™-1 and CONSERV™-2 - for ... syncytial virus (RSV) infections in children using Alnylam's RNA-interference (RNAi) technology. The RSV program also includes ALN-RSV01, for which Cubist has opt-in rights after ...
2009 NOV 23 ... impact on the growth in the wound care management market. Newer technologies such as recombinant growth factors, endovascular arterial repair techniques, bilayered human dermal ... The report also reviews the competitive landscape in terms of pipeline products and technology offerings.Wound Care Management Market to Cross $17 billion by ...
2009 NOV 23 ... his collaborators have previously demonstrated that gene transfer vectors created from recombinant crippled herpes simplex viruses can be used to deliver genes to sensory nerves from ... phase 1 trial of the preproenkephalin vector, and has licensed the patents to the vector technology. The researchers believe that the use of HSV vectors holds promise not only ...
